Drugstores Report Increased Prescriptions for Medicare Obesity Drug Program

Why it matters locally: The Medicare Bridge program's expansion of obesity drug access could impact Alaska's significant Medicare beneficiary population, potentially improving health outcomes and healthcare costs for eligible individuals across the state.

---

Drugstore chains CVS and Walgreens have each dispensed 100,000 prescriptions under a new Medicare initiative. The program, known as Bridge, launched on July 1. It provides certain Medicare beneficiaries access to obesity medications for a monthly cost of $50. The Bridge program aims to increase access to specific obesity drugs for eligible Medicare participants. CVS and Walgreens began processing these prescriptions shortly after the program's implementation.